Analog kefir production with a low phenylalanine for Phenylketonuria

Journal Title: Journal of Pharmaceutical & Health Sciences - Year 2017, Vol 5, Issue 2

Abstract

Phenylketonuria (PKU) is one of the most prevalent types of hereditary metabolic disorders which is caused due to an absence or reduction of the activity of the Phenylalanine hydroxylase enzyme in the liver which in turn, inhibits the transformation of phenylalanine (Phe) to tyrosine. In clinical terms, this disorder is displayed with severe, permanent and irreversible mental retardation. This research was aimed at development of a highly nutrient and acceptable suitable analogue Kefir drink for these patients. The mentioned drink is based on milk permeate, cream powder and includes glycomacropeptide (GMP) as a source of protein, starter as a fermentation source, the trance glutamines (TG) enzyme, dough stabilizer and modified corn starch as tissue maker, salt and water. The GMP used in this analogue drink is intended for enrichment of the product and therefore it was added by 3% to one formula. The aforementioned sample had a lower calculated amount of pH and alcohol percentage in comparison with the 16 samples which did not have GMP. The results of this study showed that the analog kefir has a low level of phenylalanine (30.40 mg/100g) and in that regard, it can be considered to be useful for patients with PKU.

Authors and Affiliations

Amir Yari, Yousef Ramezan

Keywords

Related Articles

Nutritive Value and Mineral Elements of Wild Astragalus meridioalis sensu auct. Seeds in South of Iran

Literature survey revealed that there was no biological investigation on Astragalus meridioalis sensu auct. seeds worldwide. The mature seeds of A. meridioalis was collected in August 2015 from...

Antifungal effects of crude extract and fractions of Euphorbia splendida Mobayena gainst Aspergillus niger, Aspergillus fumigatus, Candida albicans and Candida krusei

The significant decline in infectious diseases was owed to the development of the antibiotic industry. Due to the prevalence of drug-resistant organisms alongside the other problems, scientists have been focused on med...

Iran’s Pharmaceutical Sectoral Innovation System

By reviewing economic performance, two main phenomena could be identified: The first phenomenon is prior to the third wave of the Industrial Revolution in which limited resources are the predominant input; in other words...

Analog kefir production with a low phenylalanine for Phenylketonuria

Phenylketonuria (PKU) is one of the most prevalent types of hereditary metabolic disorders which is caused due to an absence or reduction of the activity of the Phenylalanine hydroxylase enzyme in the liver which in turn...

Characterization of Ceiba petandra and Lannea kerstingii Stem Bark Extract Creams

A study on physicochemical characteristics of Ceiba petandra and Lannea kerstingii stem bark extracts cream, being developed for the treatment of topical dermatophyte infections, has been carried out to assure its safe...

Download PDF file
  • EP ID EP214889
  • DOI -
  • Views 122
  • Downloads 0

How To Cite

Amir Yari, Yousef Ramezan (2017). Analog kefir production with a low phenylalanine for Phenylketonuria. Journal of Pharmaceutical & Health Sciences , 5(2), 111-120. https://europub.co.uk/articles/-A-214889